If you live in North Dakota and are looking into compounded GLP-1 medications for weight management, this page is meant to save you some digging. It covers how telehealth access works in the state, what North Dakota’s own rules say about virtual care and prescribing, what compounded semaglutide and tirzepatide actually cost, and a side-by-side look at providers that genuinely serve North Dakota, with prices pulled from their public websites rather than from ads or estimates.
One disclosure up front: this site is operated by Gentle Health, a telehealth practice that offers compounded semaglutide and tirzepatide. Gentle Health appears in the comparison table below on the same terms as everyone else.
How compounded GLP-1 access works in North Dakota
North Dakota is one of the least densely populated states in the country, and outside of Fargo, Bismarck, Grand Forks, and Minot, specialty medical care can be a long drive away. For many residents, the nearest clinic offering medical weight management is not in their town, and in winter, “a long drive” can mean something more serious than an inconvenience. That geography is a large part of why telehealth has become a practical route to this category of care in the state.
The telehealth model is straightforward. A patient completes an online health history, covering weight history, current medications, and any conditions that would make a GLP-1 medication inappropriate. A licensed physician reviews that information, conducts an evaluation consistent with North Dakota’s telemedicine requirements, and decides whether treatment is medically appropriate. If it is, a prescription goes to a licensed compounding pharmacy, and the medication ships to the patient’s home, whether that home is in Fargo or forty miles outside Williston. Follow-up happens the same way: check-ins, dose adjustments, and questions are handled remotely.
At Gentle Health, that care is provided by James Simmons, MD, who is licensed in North Dakota through the Interstate Medical Licensure Compact (license 24782, state board record), the multistate agreement that lets qualified physicians hold full licenses in member states through an expedited process. North Dakota joined the Compact precisely with rural access in mind; the Compact’s stated mission includes connecting patients in underserved and rural areas with physicians through telemedicine (IMLC). Dr. Simmons reviews each North Dakota patient’s intake personally, prescribes only where treatment is appropriate, and remains the physician of record throughout care. A prescription is never automatic; some applicants are not candidates, and an evaluation can end with a recommendation against treatment.
The North Dakota-specific licensing record, with its board-verification link, is on our North Dakota page. How the initial review itself works, asynchronous or by scheduled video, varies by state; the full breakdown is here.
North Dakota rules worth knowing
North Dakota’s telemedicine law is more clearly written than most, and it is worth knowing what it actually says.
Telemedicine is defined and permitted by statute. North Dakota Century Code chapter 43-17 defines telemedicine as the practice of medicine using electronic communication between a licensee in one location and a patient in another (N.D.C.C. ch. 43-17). The law requires a physician to establish a bona fide relationship with the patient and to perform an examination or evaluation before diagnosing or treating a specific condition. Critically, the statute states that this examination “may be performed entirely through telemedicine” if it is equivalent to an in-person examination (N.D.C.C. 43-17-44 via FindLaw). North Dakota does not require an in-person visit before a telehealth prescription for medications in this category.
Prescribing after a telemedicine exam is allowed. Under the same chapter, a physician who has performed a qualifying telemedicine evaluation may prescribe medications according to professional discretion and judgment. The notable carve-out is opioids for pain control, which cannot be prescribed via telemedicine except in specific federally approved treatment contexts. GLP-1 medications are not controlled substances, so that carve-out does not apply here.
The standard of care is the same either way. North Dakota law explicitly holds telemedicine to the same standard of care and ethical obligations as in-person medicine, a point summarized in the Center for Connected Health Policy’s state profile (CCHP: North Dakota). A physician also must verify the patient’s identity and disclose their own identity and licensure.
Physician licensure through the Compact. North Dakota is a member of the Interstate Medical Licensure Compact; the Federation of State Medical Boards announced the state’s entry, which made it the 27th state to join (FSMB). A Compact license issued for North Dakota is a full, unrestricted North Dakota medical license.
The pharmacy side. Compounded medications are prepared by state-licensed 503A compounding pharmacies for individual patients with valid prescriptions. Out-of-state pharmacies that ship into North Dakota are generally required to hold a nonresident pharmacy license from the North Dakota Board of Pharmacy. We did not find North Dakota-specific published guidance on compounded GLP-1s from the Board; the governing framework in practice is federal. After the FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, mass compounding of these drugs during the shortage era ended, and compounding is now limited to patient-specific prescriptions where the prescriber determines a compounded preparation produces a meaningful clinical difference for that individual patient (FDA statement on compounding policy). Any provider still offering compounded GLP-1s in 2026, Gentle Health included, operates within that patient-specific framework.
The practical takeaway for a North Dakota patient: the state’s rules support telehealth-based prescribing when a real evaluation happens, the physician holds a North Dakota license, and the pharmacy is properly licensed. Those are reasonable questions to ask any provider before you pay.
Compounded semaglutide in North Dakota
Semaglutide is a GLP-1 receptor agonist, a class of medication that acts on appetite regulation and gastric emptying and is prescribed, alongside diet and activity changes, for weight management. Compounded semaglutide is a version of the medication prepared by a licensed compounding pharmacy for a specific patient under a specific prescription. It is not an FDA-approved product, which means it has not gone through the FDA’s review process for safety, effectiveness, and quality the way a manufactured drug has. That is a genuine trade-off, and it is the reason the physician evaluation matters: compounded treatment is only appropriate when a prescriber determines it fits the individual patient’s situation.
For North Dakota patients, the appeal is usually cost and logistics. Manufactured GLP-1 medications frequently run to four figures per month without insurance coverage, and coverage for weight management indications remains inconsistent. Compounded semaglutide is typically a fraction of that.
Gentle Health offers compounded semaglutide to North Dakota patients in two forms, both cash-pay with dose-tiered pricing published in advance:
- Oral semaglutide: starting at $112 per month. Taken by mouth, for patients who prefer to avoid injections.
- Injectable semaglutide: starting at $135 per month. A once-weekly subcutaneous injection, the more studied route for this class.
Which form makes sense, and whether semaglutide is appropriate at all, is a decision Dr. Simmons makes with each patient during the evaluation. Common side effects in the GLP-1 class include nausea, constipation, and other gastrointestinal symptoms, particularly during dose increases, and some medical histories rule the class out entirely.
Compounded tirzepatide in North Dakota
Tirzepatide works on two receptor pathways rather than one: it is a dual GIP and GLP-1 receptor agonist. Like compounded semaglutide, compounded tirzepatide is prepared by a licensed pharmacy for an individual patient, is available only by prescription, and is not an FDA-approved product.
Gentle Health offers compounded injectable tirzepatide to North Dakota patients starting at $169 per month, cash-pay, with the price published rather than revealed after signup. As with semaglutide, treatment starts at a low dose and is adjusted gradually under Dr. Simmons’s supervision, and the evaluation comes first; tirzepatide is not the right medication for every patient, and no one is prescribed it without a medical review.
Patients sometimes ask why tirzepatide costs more than semaglutide. It is a newer, more complex molecule, and compounding pharmacies price it accordingly. Whether the difference is worth it in an individual case is a clinical conversation, not a marketing one.
Provider options in North Dakota: comparison table
Methodology: prices below were taken from each provider’s own public website on July 27, 2026; where a provider does not publish a price, we write “See site.” Rows are ordered by published semaglutide price, then alphabetically. Several national telehealth platforms have exited compounded GLP-1s since 2025, and others do not serve North Dakota, so this list reflects who we could verify actually serves the state. Gentle Health operates this site and is included on identical terms.
| Provider | Care model | Compounded semaglutide (cash/mo) | Compounded tirzepatide (cash/mo) | Serves North Dakota | Insurance | Source |
|---|---|---|---|---|---|---|
| Gentle Health (operates this site) | Telehealth; care provided by James Simmons, MD | From $112 oral / from $135 injectable | From $169 | Yes | Not accepted; cash-pay | This site - verified 2026-07-27 |
| OrderlyMeds | Telehealth | $149 ($74/mo starter offer) | $299 ($149/mo starter offer; GLP-1/GIP) | Yes (serves all 50 states) | Not required | orderlymeds.com - verified 2026-07-27 |
| Dr. Medical Health | Telehealth | $199 | From $299 | Yes (dedicated ND page) | Not required; cash, HSA, FSA | drmedhealth.com - verified 2026-07-27 |
| Henry Meds | Telehealth | See site | See site | See site | See site | henrymeds.com - verified 2026-07-30 |
| Mochi Health | Telehealth; $79/mo membership, medication billed separately | See site | See site | Yes (Bismarck location listed) | See site | joinmochi.com - verified 2026-07-27 |
A few notes for context. Membership-model providers price the subscription and the medication separately, so the monthly total depends on what is prescribed; flat-price providers fold everything into one number. None of these structures is inherently better; they suit different patients. What is worth insisting on anywhere: a real physician evaluation, a licensed US pharmacy, and a price you can see before you hand over a card number.
We computed the whole annual bill for the major programs, every fee included, in compounded GLP-1 programs compared.
Frequently asked questions
Is compounded semaglutide legal in North Dakota?
Yes, within limits. Compounding for individual patients under a valid prescription is legal under federal law (Section 503A) and North Dakota pharmacy law when performed by licensed pharmacies. Since the FDA declared the national shortages resolved, compounded GLP-1s may only be prepared patient-by-patient where the prescriber determines the compounded preparation meaningfully serves that patient’s needs. Compounded medications are not FDA-approved products, and any provider should tell you that plainly.
Do I need to see a doctor in person before getting a prescription in North Dakota?
No. North Dakota law allows the required examination to be performed entirely through telemedicine, provided it is equivalent to an in-person examination and a bona fide physician-patient relationship is established. The physician must be licensed in North Dakota and must verify your identity, and you are entitled to verify theirs.
I live in a rural area far from Fargo or Bismarck. Does that change anything?
No. Telehealth care and home delivery work the same in Bowman or Rugby as they do in Fargo. Rural access is one of the stated reasons North Dakota joined the Interstate Medical Licensure Compact. The practical considerations are an internet or phone connection for the evaluation and a reliable shipping address for the medication.
How is a physician who is not based in North Dakota licensed to treat me here?
Through the Interstate Medical Licensure Compact, which North Dakota has joined. The Compact issues full, unrestricted North Dakota licenses to qualifying physicians through an expedited process run in coordination with the North Dakota Board of Medicine. James Simmons, MD holds his North Dakota license through this pathway. You can confirm any physician’s North Dakota license through the Board’s public lookup.
Will my insurance or North Dakota Medicaid cover compounded GLP-1s?
Generally no. Because compounded medications are not FDA-approved, insurers and Medicaid programs typically do not cover them, which is why this market is almost entirely cash-pay. Gentle Health does not accept insurance; its starting prices ($112, $135, and $169 per month) are dose-tiered cash prices. If you have coverage for manufactured GLP-1 medications through your plan, that may be worth exploring with your insurer first.
What should I check before choosing a provider in North Dakota?
Four things. First, that a licensed physician actually evaluates you before anything is prescribed. Second, that the physician holds a North Dakota license you can verify with the state Board of Medicine. Third, that the pharmacy is a licensed US compounding pharmacy, and if out of state, holds a North Dakota nonresident pharmacy license. Fourth, that pricing is published before you commit. A provider that resists any of these questions has answered them.
What do compounded GLP-1s actually cost in North Dakota?
Among providers we verified serving the state with published prices, compounded semaglutide runs from $112 to $199 per month and compounded tirzepatide from $169 to roughly $299 per month, all cash-pay. Providers that do not publish prices may fall inside or outside those ranges; the only way to know is to ask them directly, in writing, before you pay.
Current Gentle Health dose tiers and pricing
Gentle Health pricing depends on the dose tier prescribed by your clinician. Current monthly prices are:
Oral compounded semaglutide
| Tier | Daily dose | Monthly price |
|---|---|---|
| Starting | 2-4 mg/day | $112/mo |
| Medium | >4-8 mg/day | $189/mo |
| High dose | >8-12 mg/day | $258/mo |
Injectable compounded semaglutide
| Tier | Weekly dose | Monthly price |
|---|---|---|
| Starting | 0.24-0.48 mg/wk | $135/mo |
| Medium | >0.48-1.2 mg/wk | $159/mo |
| High dose | >1.2-2.4 mg/wk | $199/mo |
Injectable compounded tirzepatide
| Tier | Weekly dose | Monthly price |
|---|---|---|
| Starting | 2.5-5 mg/wk | $169/mo |
| Medium | >5-10 mg/wk | $219/mo |
| High dose | >10-15 mg/wk | $269/mo |
Medication, the initial review by a licensed clinician, video visits and messaging, and overnight refrigerated shipping are included. There is no separate membership fee, and HSA and FSA cards are accepted. Your clinician determines the appropriate medication and dose; the monthly price changes if the prescribed dose moves into a different tier.
Gentle Health serves patients across a growing multistate footprint through clinicians licensed in each patient’s jurisdiction, including North Dakota.
Reviewed by James Simmons, MD
Compounded medications are not FDA-approved. Treatment subject to medical evaluation.